Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one milliliter of peripheral blood: Value for the staging of prostate cancer

Clinical Cancer Research

Volumn 8, Issue 6, 2002, Pages 1794-1799

  Hara, Noboru ^a   Kasahara, Takashi ^a   Kawasaki, Takashi ^a   Bilim, Vladimir ^a   Obara, Kenji ^a   Takahashi, Kota ^a   Tomita, Yoshihiko ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; PROSTATE SPECIFIC MEMBRANE ANTIGEN; PROSTATE STEM CELL ANTIGEN; RNA; UNCLASSIFIED DRUG;

ANTIGEN DETECTION; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION;

DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DNA PRIMERS; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS; NEOPLASM STAGING; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036282360     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Cancer statistics, 2001
2. Cancer statistics digest. Comparison of crude and age-standardized death rates in Japan
3. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6,630 men
4. Comparison of perspectives on prostate cancer: Analyses of survey data
5. Blood-based reverse transcriptase polymerase chain reaction assays for prostatic specific antigen: Long term follow-up confirms the potential utility of this assay in identifying patients more likely to have biochemical recurrence (rising PSA) following radical prostatectomy
6. The value of a reverse transcriptase polymerase chain reaction assay in preoperative staging and followup of patients with prostate cancer
7. Detection of disseminated prostate cells by reverse transcription-polymerase chain reaction (RT-PCR): Technical and clinical aspects
8. The use of flow cytometry and RT-PCR in the detection of circulating PSA-positive cells in prostate cancer
9. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer
10. Prostate specific antigen and androgen receptor induction and characterization of an immortalized adult human prostatic epithelial cell line
11. Molecular cloning of a complimentary DNA encoding a prostate-specific membrane antigen
12. Expression of the prostate-specific membrane antigen
13. Metastatic renal cell carcinoma neovasculature expresses prostatespecific membrane antigen
14. Stem cell antigen 2 expression in adult and developing mice
15. Coamplification of prostate stem cell antigen (PSCA) and MYC in locally advanced prostate cancer
16. International consultation on urological diseases: A decade of progress
17. Frequency of PSA-mRNA bearing cells in the peripheral blood of patients after prostate biopsy
18. Efficient isolation of total RNA from Clostridium without DNA contamination
19. Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer
20. Competing-risk analysis of leukemia and nonleukemia mortality in irradiated, male RF mice
21. Blood-based RT-PCR assays of MN/CA9 or PSMA: Clinical application in renal cancer patients
22. Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy
23. Detection of circulating prostate-specific antigenpositive cells in patients with prostate cancer by flow cytometry and reverse transcription polymerase chain reaction
24. Detection of metastatic prostate cancer using a splice variant-specific reverse transcriptase-polymerase chain reaction assay for human glandular kallikrein
25. Detection of circulating prostate derived cells in patients with prostate adenocarcinoma is an independent risk factor for tumor recurrence
26. Detection of extraprostatic prostate cells utilizing reverse transcription-polymerase chain reaction
27. 0 prostate cancer
28. Utilization of polymerase chain reaction technology in the detection of solid tumors
29. The significance of hematogenous tumor cell clumps in the metastatic process
30. Circulating prostate specific antigen-positive cells correlate with metastatic prostate cancer
31. Critical factors in the biology of human cancer metastasis: Twenty-eighth G. H. A. Clowes memorial award lecture
32. Defining prostate specific antigen progression after radical prostatectomy: What is the most appropriate cut point?
33. Acute bacterial prostatitis induces hematogenous dissemination of prostate epithelial cells
34. Identification, purification, and subcellular localization of prostate-specific membrane antigen PSM' protein in the LNCaP prostatic carcinoma cell line
35. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow
36. Prostate stem cell antigen (PSCA) expression increases with high Gleason score, advanced stage and bone metastasis in prostate cancer